Immune cells, such as macrophages, B cells, neutrophils and T cell subsets, have been implicated in the context of obesity. However, the specific role of Th2 cells in adipose tissue function has remained elusive. Eight-week-old male CD3ε ─/─ mice were randomly divided into two groups (≥ 5 mice per group): one received intravenous injection of Th2 cells isolated from LAT Y136F mice, while the other receiving PBS as a control. Both of groups were subjected to a high-fat diet (HFD). The adoptive transfer of polarized Th2 cells led to a significant reduction in obesity following a HFD. This reduction was accompanied by improvements in hepatic steatosis, glucose intolerance, and insulin resistance. Mechanistically, Th2 cell treatment promoted oxidative phosphorylation of adipocytes, thereby contributing to a reduction of lipid droplet accumulation. These findings suggest that Th2 cell therapy represents a novel approach for treating diet-induced obesity and other diseases involving lipid droplet accumulation disorders.
Keyphrases
- high fat diet induced
- insulin resistance
- high fat diet
- adipose tissue
- induced apoptosis
- cell therapy
- metabolic syndrome
- skeletal muscle
- type diabetes
- polycystic ovary syndrome
- cell cycle arrest
- endoplasmic reticulum stress
- single cell
- physical activity
- oxidative stress
- mesenchymal stem cells
- signaling pathway
- glycemic control
- weight loss
- high dose
- high throughput
- placebo controlled
- replacement therapy